Ho Chi Sing 13D/13G Filings for CASI Pharmaceuticals, Inc. (CASIF)

Ho Chi Sing 13D and 13G filings for CASI Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-20
09:33 am
Unchanged
2025-09-3013DCASI PHARMACEUTICALS HLDGS INC
CASIF
Ho Chi Sing992,638
4.800%
0
(Unchanged)
Filing
2025-02-03
8:17 pm
Purchase
2024-12-3013DCASI PHARMACEUTICALS HLDGS INC
CASIF
Ho Chi Sing992,638
6.400%
992,638increase
(New Position)
Filing